Carregant...
An Update on the Reversal of Non-Vitamin K Antagonist Oral Anticoagulants
Non-vitamin K antagonist oral anticoagulants (NOACs) include thrombin inhibitor dabigatran and coagulation factor Xa inhibitors rivaroxaban, apixaban, edoxaban, and betrixaban. NOACs have several benefits over warfarin, including faster time to the achieve effect, rapid onset of action, fewer docume...
Guardat en:
| Publicat a: | Adv Hematol |
|---|---|
| Autors principals: | , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Hindawi
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7097770/ https://ncbi.nlm.nih.gov/pubmed/32231703 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2020/7636104 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|